A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma-Reference-Cited by-同舟云学术

A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma

Published:2017-07-26 Issue:2 Volume:135 Page:307-315
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Veldhuijzen van Zanten Sophie E. M.,El-Khouly Fatma E.^ORCID,Jansen Marc H. A.,Bakker Dewi P.,Sanchez Aliaga Esther,Haasbeek Cornelis J. A.,Wolf Nicole I.,Zwaan C. Michel,Vandertop W. Peter,van Vuurden Dannis G.,Kaspers Gertjan J. L.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/article/10.1007/s11060-017-2575-9/fulltext.html

Reference28 articles.

1. Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248. doi: 10.1016/S1470-2045(06)70615-5

2. Jansen MHA, van Vuurden DG, Vandertop WP, Kaspers GJL (2012) Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat Rev 38:27–35. doi: 10.1016/j.ctrv.2011.06.007

3. Langmoen IA, Lundar T, Storm-Mathisen I et al (1991) Management of pediatric pontine gliomas. Childs Nerv Syst 7:13–15

4. Sigmond J, Honeywell RJ, Postma TJ et al (2008) Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer. doi: 10.1093/annonc/mdn543

5. Pauwels B, Korst AEC, Lardon F, Vermorken JB (2005) Combined modality therapy of gemcitabine and radiation. Oncologist 10:34–51. doi: 10.1634/theoncologist.10-1-34

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice;Practical Radiation Oncology;2024-09

2. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy;European Journal of Pharmaceutics and Biopharmaceutics;2024-07

3. Repurposing gemcitabine for glioblastoma treatment: The role of drug-conjugates and nanoparticles as drug delivery systems;Journal of Drug Delivery Science and Technology;2024-06

4. Fimepinostat impairs NFκB and PI3K/AKT signaling and enhances gemcitabine efficacy in H3K27M-mutated diffuse intrinsic pontine glioma;Cancer Research;2023-12-14

5. Advances in Treatment of Diffuse Midline Gliomas;Current Neurology and Neuroscience Reports;2023-11-03